Metformin use and cirrhotic decompensation in patients with type 2 diabetes and liver cirrhosis.

Fu-Shun YenYi-Hsiang HuangMing-Chih HouChii-Min HwaYu-Ru LoShyi-Jang ShinChih-Cheng Hsu

Published in: British journal of clinical pharmacology (2021)

Metformin use was associated with higher risks of mortality and cirrhotic decompensation in patients with compensated liver cirrhosis. Prospective studies are required to confirm our results.

Keyphrases

cardiovascular events
human health
risk factors
case control
coronary artery disease